| Literature DB >> 27999108 |
Ana M Fernandez1,2, Edwin Hernandez-Garzón1,2, Paloma Perez-Domper1,2, Alberto Perez-Alvarez1,3, Sara Mederos1, Takashi Matsui4, Andrea Santi1,2, Angel Trueba-Saiz1,2, Lucía García-Guerra2,5, Julia Pose-Utrilla2,5, Jens Fielitz6,7, Eric N Olson8, Ruben Fernandez de la Rosa9, Luis Garcia Garcia9, Miguel Angel Pozo9, Teresa Iglesias2,5, Alfonso Araque1, Hideaki Soya4, Gertrudis Perea1, Eduardo D Martin10, Ignacio Torres Aleman11,2.
Abstract
Brain activity requires a flux of glucose to active regions to sustain increased metabolic demands. Insulin, the main regulator of glucose handling in the body, has been traditionally considered not to intervene in this process. However, we now report that insulin modulates brain glucose metabolism by acting on astrocytes in concert with IGF-I. The cooperation of insulin and IGF-I is needed to recover neuronal activity after hypoglycemia. Analysis of underlying mechanisms show that the combined action of IGF-I and insulin synergistically stimulates a mitogen-activated protein kinase/protein kinase D pathway resulting in translocation of GLUT1 to the cell membrane through multiple protein-protein interactions involving the scaffolding protein GAIP-interacting protein C terminus and the GTPase RAC1. Our observations identify insulin-like peptides as physiological modulators of brain glucose handling, providing further support to consider the brain as a target organ in diabetes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27999108 DOI: 10.2337/db16-0861
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461